Package 21130-081-05

{"route": ["ORAL"], "spl_id": "27d89a75-79e6-3b34-e063-6394a90a7d7d", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["198467"], "spl_set_id": ["96359eb6-62bc-4b13-960c-050af99a8c02"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Safeway"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, DELAYED RELEASE in 1 BOTTLE (21130-081-05)", "package_ndc": "21130-081-05", "marketing_start_date": "20150805"}], "brand_name": "Enteric Coated Aspirin Regular Strength", "product_id": "21130-081_27d89a75-79e6-3b34-e063-6394a90a7d7d", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "21130-081", "generic_name": "Aspirin", "labeler_name": "Safeway", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Enteric Coated Aspirin", "brand_name_suffix": "Regular Strength", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20150805", "listing_expiration_date": "20261231"}